Ahadi M, Molooghi K, Masoudifar N, Namdar AB, Vossoughinia H, Farzanehfar M (2021) A review of non-alcoholic fatty liver disease in non-obese and lean individuals. J Gastroenterol Hepatol 36:1497–1507. https://doi.org/10.1111/jgh.15353
Askari F, Rashidkhani B, Hekmatdoost A (2014) Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutrition research (New York, NY) 34:143–148. https://doi.org/10.1016/j.nutres.2013.11.005
Asrih M, Jornayvaz F (2013) Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol 218:R25-36. https://doi.org/10.1530/joe-13-0201
CAS Article PubMed Google Scholar
Perry R, Kim T, Zhang X, Lee H, Pesta D, Popov V, Zhang D, Rahimi Y, Jurczak M, Cline G et al (2013) Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. Cell Metab 18:740–748. https://doi.org/10.1016/j.cmet.2013.10.004
CAS Article PubMed PubMed Central Google Scholar
Watt MJ, Miotto PM, De Nardo W, Montgomery MK (2019) The liver as an endocrine organ-linking NAFLD and insulin resistance. Endocr Rev 40:1367–1393. https://doi.org/10.1210/er.2019-00034
Cobbina E, Akhlaghi F (2017) Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev 49:197–211. https://doi.org/10.1080/03602532.2017.1293683
CAS Article PubMed PubMed Central Google Scholar
Gaggini M, Morelli M, Buzzigoli E, DeFronzo R, Bugianesi E, Gastaldelli A (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5:1544–1560. https://doi.org/10.3390/nu5051544
CAS Article PubMed PubMed Central Google Scholar
Zhang J, Wang L, Xu J, Tang Y, Huang B, Chen Z, Zhang T, Shen HM, Wu Y, Xia D (2020) Bone marrow stromal cell-derived growth inhibitor serves as a stress sensor to induce autophagy. FEBS Lett 594:1248–1260. https://doi.org/10.1002/1873-3468.13732
CAS Article PubMed Google Scholar
Corà D, Bussolino F, Doronzo G (2021) TFEB signalling-related microRNAs and autophagy. Biomolecules. https://doi.org/10.3390/biom11070985
Article PubMed PubMed Central Google Scholar
Martina JA, Chen Y, Gucek M, Puertollano R (2012) MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8:903–914. https://doi.org/10.4161/auto.19653
CAS Article PubMed PubMed Central Google Scholar
Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, Walther TC, Ferguson SM (2012) The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 5:ra42. https://doi.org/10.1126/scisignal.2002790
Xu Y, Ren J, He X, Chen H, Wei T, Feng W (2019) YWHA/14-3-3 proteins recognize phosphorylated TFEB by a noncanonical mode for controlling TFEB cytoplasmic localization. Autophagy 15:1017–1030. https://doi.org/10.1080/15548627.2019.1569928
CAS Article PubMed PubMed Central Google Scholar
Yan S (2022) Role of TFEB in autophagy and the pathogenesis of liver diseases. Biomolecules. https://doi.org/10.3390/biom12050672
Article PubMed PubMed Central Google Scholar
Yu S, Wang Z, Ding L, Yang L (2020) The regulation of TFEB in lipid homeostasis of non-alcoholic fatty liver disease: molecular mechanism and promising therapeutic targets. Life Sci 246:117418. https://doi.org/10.1016/j.lfs.2020.117418
CAS Article PubMed Google Scholar
Pan Q, Lin S, Li Y, Liu L, Li X, Gao X, Yan J, Gu B, Chen X, Li W et al (2021) A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis. EBioMedicine 63:103202. https://doi.org/10.1016/j.ebiom.2020.103202
CAS Article PubMed PubMed Central Google Scholar
Gong Q, Hu Z, Zhang F, Cui A, Chen X, Jiang H, Gao J, Chen X, Han Y, Liang Q et al (2016) Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice. Hepatology (Baltimore, MD) 64:425–438. https://doi.org/10.1002/hep.28523
Gao Y, Zhang W, Zeng LQ, Bai H, Li J, Zhou J, Zhou GY, Fang CW, Wang F, Qin XJ (2020) Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox Biol 36:101635. https://doi.org/10.1016/j.redox.2020.101635
CAS Article PubMed PubMed Central Google Scholar
Ren H, Wang D, Zhang L, Kang X, Li Y, Zhou X, Yuan G (2019) Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice. Aging (Albany NY) 11:9461–9477. https://doi.org/10.18632/aging.102396
Settembre C, Zoncu R, Medina D, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard M et al (2012) A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31:1095–1108. https://doi.org/10.1038/emboj.2012.32
CAS Article PubMed PubMed Central Google Scholar
Martina JA, Puertollano R (2013) Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes. J Cell Biol 200:475–491. https://doi.org/10.1083/jcb.201209135
CAS Article PubMed PubMed Central Google Scholar
Zhang H, Yan S, Khambu B, Ma F, Li Y, Chen X, Martina J, Puertollano R, Li Y, Chalasani N et al (2018) Dynamic MTORC1-TFEB feedback signaling regulates hepatic autophagy, steatosis and liver injury in long-term nutrient oversupply. Autophagy 14:1779–1795. https://doi.org/10.1080/15548627.2018.1490850
CAS Article PubMed PubMed Central Google Scholar
Iroz A, Montagner A, Benhamed F, Levavasseur F, Polizzi A, Anthony E, Régnier M, Fouché E, Lukowicz C, Cauzac M et al (2017) A specific ChREBP and PPARα cross-talk is required for the glucose-mediated FGF21 response. Cell Rep 21:403–416. https://doi.org/10.1016/j.celrep.2017.09.065
CAS Article PubMed PubMed Central Google Scholar
Chen L, Wang K, Long A, Jia L, Zhang Y, Deng H, Li Y, Han J, Wang Y (2017) Fasting-induced hormonal regulation of lysosomal function. Cell Res 27:748–763. https://doi.org/10.1038/cr.2017.45
CAS Article PubMed PubMed Central Google Scholar
Fang Y, Ji L, Zhu C, Xiao Y, Zhang J, Lu J, Yin J, Wei L (2020) Liraglutide alleviates hepatic steatosis by activating the TFEB-regulated autophagy-lysosomal pathway. Frontiers in cell and developmental biology 8:602574. https://doi.org/10.3389/fcell.2020.602574
Article PubMed PubMed Central Google Scholar
Sardiello M, Palmieri M, di Ronza A, Medina D, Valenza M, Gennarino V, Di Malta C, Donaudy F, Embrione V, Polishchuk R et al (2009) A gene network regulating lysosomal biogenesis and function. Science (New York, NY) 325:473–477. https://doi.org/10.1126/science.1174447
留言 (0)